FDA clearance for the new WatchPATTM Central Plus

The new device will enable specific identification and reporting of Central Sleep Apnea (CSA).
With this new capability, patients suspected of having sleep apnea can be diagnosed more specifically with an exceptionally easy to use, automated and accurate WatchPAT HSAT device and benefit from optimized treatment.